Maravai LifeSciences Holdings, Inc. MRVI Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$6.38M+89.9% | -$63.02M-39.9% | -$45.06M+35.5% | -$69.84M-32.1% | -$52.85M-14.7% | ||
| $4.9M-17.4% | $5.93M-0.7% | $5.98M+0.3% | $5.96M+4.6% | $5.69M+4.2% | ||
| $6.74M+71.8% | $3.93M-56.6% | $9.06M+33.4% | $6.79M-34.7% | $10.4M-1.3% | ||
| $605K-98.5% | $41.71M— | $0-100% | $30.45M+145% | $12.44M+4.0% | ||
| $7.91M— | —— | -$5.12M-921% | -$501K+95.1% | -$10.16M— | ||
| -$33K+98.9% | -$3.09M-129% | -$1.35M+56.6% | -$3.11M-592% | -$449K+0.7% | ||
| $6.16M+212% | -$5.52M-89.8% | -$2.91M-263% | $1.78M+352% | -$708K-131% | ||
| -$5.34M+60.5% | -$13.51M-993% | $1.51M-72.7% | $5.54M+201% | $1.84M+218% | ||
| -$1.43M-21.3% | -$1.18M-10.8% | -$1.07M-137% | $2.86M+228% | -$2.24M-166% | ||
| -$203K+89.3% | -$1.89M+8.1% | -$2.06M+66.7% | -$6.19M+27.1% | -$8.49M-638% | ||
| -$541K— | —— | -$334K+54.4% | -$732K-225% | -$225K— | ||
| $6.47M-0.6% | $6.51M-9.7% | $7.21M+0.1% | $7.2M+2.4% | $7.03M+1.9% | ||
| $1.61M-29.8% | $2.29M+1.3% | $2.26M+1.3% | $2.23M+1.9% | $2.19M+1.3% | ||
| $8.67M+138% | -$22.77M-50.3% | -$15.15M-47.6% | -$10.27M-9.3% | -$9.39M— | ||
| $4.44M+110% | $2.11M-27.8% | $2.93M-18.9% | $3.61M-19.8% | $4.5M-23.0% | ||
| $0— | —— | —— | $362K-98.1% | $18.63M— | ||
| —— | $0— | $0— | $0— | $0-100% | ||
| -$4.44M-110% | -$2.11M+27.8% | -$2.93M+9.6% | -$3.24M+86.0% | -$23.13M-369% | ||
| $51.36M+3,676% | $1.36M0.0% | $1.36M0.0% | $1.36M0.0% | $1.36M-99.4% | ||
| -$3.87M— | —— | —— | —— | -$3.54M— | ||
| -$55.23M-2,941% | -$1.82M+78.0% | -$8.25M-438% | -$1.53M+68.7% | -$4.9M+97.9% | ||
| $30K— | —— | -$8K+92.8% | -$111K-252% | $73K— | ||
| -$50.97M-91.0% | -$26.68M-1.3% | -$26.33M-73.9% | -$15.15M+59.4% | -$37.35M+85.4% | ||
| $6.15M-1.0% | $6.21M+1.2% | $6.13M+0.2% | $6.12M-6.1% | $6.52M-56.9% | ||
| $0— | $0+100% | -$26K+96.1% | -$674K-585% | $139K+435% | ||
| $6.47M-0.6% | $6.51M-9.7% | $7.21M+0.1% | $7.2M+2.4% | $7.03M+1.9% | ||
| $605K— | —— | —— | —— | $12.44M-70.1% | ||
| $4.9M-17.4% | $5.93M-0.7% | $5.98M+0.3% | $5.96M+4.6% | $5.69M+4.2% | ||
| -$203K+89.3% | -$1.89M+8.1% | -$2.06M+66.7% | -$6.19M+27.1% | -$8.49M-638% | ||
| —— | -$45.25K0.0% | -$45.25K0.0% | -$45.25K0.0% | -$45.25K-18.3% | ||
| -$1.43M-21.3% | -$1.18M-10.8% | -$1.07M-137% | $2.86M+228% | -$2.24M-166% | ||
| $1.61M-29.8% | $2.29M+1.3% | $2.26M+1.3% | $2.23M+1.9% | $2.19M+1.3% | ||
| -$541K— | —— | -$334K+54.4% | -$732K-225% | -$225K— | ||
| —— | $0— | $0— | $0— | $0-100% | ||
| —— | -$2.5K0.0% | -$2.5K0.0% | -$2.5K0.0% | -$2.5K-102% | ||
| —— | $0— | $0— | $0— | $0-100% | ||
| -$3.87M— | —— | —— | —— | -$3.54M-704% | ||
| $248K-91.0% | $2.75M— | —— | $288K-79.9% | $1.43M+76.8% | ||
| $0— | —— | —— | —— | $4.8M— | ||
| $0— | —— | —— | —— | $2.33M— | ||
| $0— | $0+100% | -$26K+96.1% | -$674K-585% | $139K+435% | ||
| $4.23M+117% | -$24.88M-37.7% | -$18.08M-30.3% | -$13.87M+0.1% | -$13.89M+32.2% | ||
| $4.23M+117% | -$24.88M-37.7% | -$18.08M-30.3% | -$13.87M+0.1% | -$13.89M+32.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Maravai LifeSciences Holdings, Inc. generate?
- Maravai LifeSciences Holdings, Inc. (MRVI) generated -$39.5M in operating cash flow over the trailing twelve months.
- What is Maravai LifeSciences Holdings, Inc.'s free cash flow?
- After $13.1M of capital expenditures, Maravai LifeSciences Holdings, Inc.'s free cash flow was -$52.6M over the trailing twelve months, down 283.3% year over year.
- Where does Maravai LifeSciences Holdings, Inc.'s cash flow data come from?
- Every line is extracted from Maravai LifeSciences Holdings, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
